Bank of New York Mellon Corp - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,741,937
+1.4%
168,006
+4.3%
0.00%
+50.0%
Q2 2023$11,575,641
+50.0%
161,086
+28.7%
0.00%0.0%
Q1 2023$7,717,155
-22.1%
125,116
-2.6%
0.00%0.0%
Q4 2022$9,911,050
+64.3%
128,498
-4.9%
0.00%
+100.0%
Q3 2022$6,031,000
+34.1%
135,130
+15.1%
0.00%0.0%
Q2 2022$4,497,000
+3.0%
117,410
+11.4%
0.00%0.0%
Q1 2022$4,364,000
-5.3%
105,423
-13.6%
0.00%0.0%
Q4 2021$4,608,000
-4.5%
121,979
-16.7%
0.00%0.0%
Q3 2021$4,827,000
-48.3%
146,406
+5.9%
0.00%
-50.0%
Q2 2021$9,329,000
+13.6%
138,299
-4.6%
0.00%0.0%
Q1 2021$8,209,000
-33.0%
144,974
-3.6%
0.00%
-33.3%
Q4 2020$12,255,000
+15.8%
150,419
+1.3%
0.00%0.0%
Q3 2020$10,584,000
-12.5%
148,559
+1.0%
0.00%0.0%
Q2 2020$12,099,000
+34.3%
147,039
-4.0%
0.00%0.0%
Q1 2020$9,011,000
-40.5%
153,181
+4.5%
0.00%
-25.0%
Q4 2019$15,155,000
+355.2%
146,625
-10.8%
0.00%
+300.0%
Q3 2019$3,329,000
-21.4%
164,451
+0.0%
0.00%0.0%
Q2 2019$4,233,000
+238.6%
164,396
+87.2%
0.00%
Q1 2019$1,250,000
+1175.5%
87,841
+153.2%
0.00%
Q4 2018$98,000
+11.4%
34,690
+52.7%
0.00%
Q1 2017$88,000
-57.7%
22,723
-26.5%
0.00%
Q4 2016$208,000
+23.1%
30,918
+44.8%
0.00%
Q3 2016$169,000
+5.0%
21,3540.0%0.00%
Q2 2016$161,000
+50.5%
21,354
+85.5%
0.00%
Q4 2015$107,00011,5120.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,009,799$82,268,00041.24%
Fairmount Funds Management LLC 220,098$17,931,0006.41%
WMS Partners, LLC 250,000$20,368,0003.51%
IRIDIAN ASSET MANAGEMENT LLC/CT 2,064,158$168,167,0003.06%
MORGAN JESS S & CO INC 44,468$3,623,0002.88%
RTW INVESTMENTS, LP 1,672,416$136,252,0002.29%
RA Capital Management 1,655,447$134,869,0001.88%
Nicholas Investment Partners, LP 207,452$16,901,0001.30%
Affinity Asset Advisors, LLC 25,000$2,037,0001.08%
Parkman Healthcare Partners LLC 30,758$2,506,0000.64%
View complete list of AXSOME THERAPEUTICS INC shareholders